Shares of Pluri Inc. (NASDAQ:PLUR – Get Free Report) were up 1.2% on Tuesday . The company traded as high as $5.25 and last traded at $5.25. Approximately 6,367 shares were traded during trading, a decline of 60% from the average daily volume of 15,868 shares. The stock had previously closed at $5.19.
Pluri Trading Down 3.5 %
The business has a 50 day moving average of $5.51 and a two-hundred day moving average of $5.87. The company has a debt-to-equity ratio of 13.04, a quick ratio of 6.05 and a current ratio of 6.05. The firm has a market capitalization of $27.11 million, a price-to-earnings ratio of -1.22 and a beta of 1.60.
About Pluri
Pluri Inc, a biotechnology company, engages in the development of placenta-based cell therapy product candidates for the treatment of inflammatory, muscle injuries, and hematologic conditions. It operates in the field of regenerative medicine, food-tech, and biologics and focuses on establishing partnerships that leverage its 3D cell-based technology to additional industries that require mass cell production.
See Also
- Five stocks we like better than Pluri
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- 3 Leveraged ETFs to Multiply Returns
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- A Tale of Two Titans: Unveiling the Value in Baidu and JD.com
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Is the AI-Capable iPhone 16 the Start of a Sales Super-Cycle?
Receive News & Ratings for Pluri Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pluri and related companies with MarketBeat.com's FREE daily email newsletter.
